Axogen (AXGN) Cash from Operations (QoQ) (2010 - 2026)
Axogen (AXGN) Cash from Operations (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Axogen | 2.44 Bn | 2.33 Bn | 50.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 361.41% |
| Mar 31, 2026 | -48.49% |
| Dec 31, 2025 | -5.74% |
| Sep 30, 2025 | -58.31% |
| Jun 30, 2025 | 158.65% |
| Mar 31, 2025 | -250.88% |
| Dec 31, 2024 | 123.92% |
| Sep 30, 2024 | -6.34% |
| Jun 30, 2024 | 133.96% |
| Mar 31, 2024 | -5,713.27% |
| Dec 31, 2023 | -112.98% |
| Sep 30, 2023 | 456.85% |
| Jun 30, 2023 | 103.93% |
| Mar 31, 2023 | -645.01% |
| Dec 31, 2022 | 297.68% |
| Sep 30, 2022 | 87.89% |
| Jun 30, 2022 | 48.53% |
| Mar 31, 2022 | -629.92% |
| Dec 31, 2021 | -302.66% |
| Sep 30, 2021 | 45.90% |